NEXUS AG

NXU

Equity

ISIN DE0005220909 / Valor 1099292

Xetra (2024-11-22)

EUR 68.50+0.29%

NEXUS AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

NEXUS AG is a European company specializing in the development of innovative software solutions for the healthcare sector. Their product offerings include a clinical information system (NEXUS / KIS) and integrated diagnostic modules (NEXUS / DIS), designed to meet the wide-ranging functional requirements of hospitals, psychiatric institutions, rehabilitation, and diagnostic centers. The company focuses on creating user-friendly process support tools that enhance efficiency and safety in patient care. With over 250,000 daily users, including doctors, nurses, and administrative staff across various healthcare facilities, NEXUS AG emphasizes close customer relationships and localized support. Employing approximately 1,700 staff members, the company operates in seven European countries and serves clients in an additional 23 countries through certified dealers. NEXUS AG's growth is evidenced by its expanding customer base and consistently increasing revenues and profits.

Summarized from source with an LLMView SourceSector: Technology

Sales Growth

NEXUS AG reported a significant increase in sales for the first quarter of 2024, with sales rising by 14.5% from KEUR 55,020 to KEUR 62,988. This growth continues the positive trend observed in previous years.

EBITDA Improvement

The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) saw a notable improvement, increasing by 11.7% to KEUR 12,953 in Q1 2024, compared to KEUR 11,602 in the same period of the previous year.

EBIT Increase

NEXUS AG's earnings before interest and taxes (EBIT) rose by 8.9% in the first quarter of 2024, reaching KEUR 8,373, up from KEUR 7,688 in Q1 2023. This reflects the company's strong operational performance.

Consolidated Surplus

The consolidated surplus for NEXUS AG increased sharply by 18.4% to KEUR 6,695 in Q1 2024, compared to KEUR 5,654 in the same quarter of the previous year, indicating robust profitability.

Cash Resources

As of March 31, 2024, NEXUS AG had cash resources amounting to KEUR 117,219, up from KEUR 97,434 at the end of 2023. This strong cash position underscores the company's financial stability and liquidity.

Summarized from source with an LLMView Source

Key figures

21.9%1Y

-3.25%3Y

109%5Y

Performance

43.5%1Y

39.8%3Y

39.7%5Y

Volatility